Suma Krishnan sold $8.9M of KRYS
President, R&D at Krystal Biotech, Inc.. 50,000 shares at an average of $177.79, traded Mar 13, 2025, filed Mar 13, 2025.
Score components
- +20RolePresident
- +25Trade size$8.9M at market
- 0Share of holdings soldSold 3.4% of holdings
- +15Cluster3 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.0%, 3m -20.9%, 6m -18.6%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001298711-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 13, 2025 | SOpen-market sale Common Stock10b5-1 | -1,639 | $175.97 | $288k | 1,487,072 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stock10b5-1 | -4,579 | $176.88 | $810k | 1,482,493 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stock10b5-1 | -10,937 | $177.66 | $1.9M | 1,471,556 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stock10b5-1 | -6,514 | $178.76 | $1.2M | 1,465,042 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stock10b5-1 | -1,331 | $179.55 | $239k | 1,463,711 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,100 | $175.83 | $193k | 1,556,956 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -4,944 | $176.80 | $874k | 1,552,012 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -10,931 | $177.62 | $1.9M | 1,541,081 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -6,769 | $178.77 | $1.2M | 1,534,312 | Mar 13, 2025 |
| Mar 13, 2025 | SOpen-market sale Common Stockindirect: By Spouse10b5-1 | -1,256 | $179.57 | $226k | 1,533,056 | Mar 13, 2025 |
Related signals
Other insiders at Krystal Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $9.0M 25,000 shares | -2% | |
| 33Weak | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $9.0M 25,000 shares | -2% | |
| 50Moderate | KRYSsell Krystal Biotech, Inc. | Dino A Rossi director | $8.2M 25,000 shares | -33% | |
| 15Weak | Krystal Biotech, Inc. | John Charles Thomas EVP, General Counsel | $347k 1,000 shares | -100% | |
| 45Moderate | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $7.7M 25,000 shares | -2% | |
| 40Moderate | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $7.7M 25,000 shares | -2% | |
| 42Moderate | Krystal Biotech, Inc. | John Charles Thomas EVP, General Counsel | $194k 642 shares | -100% | |
| 45Moderate | Krystal Biotech, Inc. | Krish S Krishnan President and CEO | $6.6M 25,000 shares | -2% | |
| 40Moderate | Krystal Biotech, Inc. | Suma Krishnan President, R&D | $6.6M 25,000 shares | -2% | |
| 40Moderate | Krystal Biotech, Inc. | Daniel Janney director | $3.3M 11,803 shares | -14% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.